Buyer's Guide
Country:
Zipcode:
Operation:
Search for:
Companies Products Countries ZIP Code (Germany) New Companies
0-9   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Contact | Print version | PDF version | Recommend company

SemBioSys Genetics Inc.
110, 2985 - 23rd Avenue N.E.
T1Y 7L3 Calgary, AB
Canada

Phone:  +14032505424
Fax:  +14032503886

Contact / Request Information

Portrait
Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates, produced in the plant host safflower, are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products, SemBioSys is developing a series of non-pharmaceutical products addressing human topical, nutritional oils and agricultural biotechnology markets.

Industrial Sectors
  • Pharmacy

      Firma bearbeiten
      Firma eintragen
       
      Additional information

      SemBioSys Genetics Inc.
      Calgary, AB, Canada

      News
      - 18 Mar 2008 - SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
      - 16 Jul 2007 - Plants produce recombinant apolipoprotein AI on a commercial level
      - 27 Nov 2006 - SemBioSys signs contract manufacturing agreement for plant-produced insulin with Cangene
       more news
      MyBionity.COM
      Newsletter Subscription
      Your e-mail:
      Top  
      © 2001-2008 Chemie.DE Information Service GmbH
      a Life Science Network Division

       www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET